ASND Stock: Ascendis Pharma A/S Stock Price, Analysis & Insights
Get live ASND stock price $209.79, comprehensive Ascendis Pharma A/S stock analysis, charts, news, and expert forecast. Real-time ASND stock data and investment insights.
Loading chart data...
Ascendis Pharma A/S (ASND) Overview
Ascendis Pharma A/S (ASND) is a publicly traded company in the Healthcare sector , specifically within the Biotechnology industry . As of the latest trading session, ASND trades at $209.79 with a market capitalization of 12.96B . Over the past 52 weeks, ASND has traded between $160.86 and $250.74 , with the current price positioned at approximately 54% of this range . The stock currently trades...
Key Takeaways
- Operates in the Healthcare sector (Biotechnology)
- Market cap: 12.96B
- Current price: $209.79
- 52-week range: $160.86 - $250.74
- P/E ratio: 24.06
Investment Score
A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
Ascendis Pharma A/S is a biopharmaceutical enterprise dedicated to advancing therapeutic solutions for critical medical conditions that currently lack effective treatments. Its commercialized offering is SKYTROFA, a therapy prescribed for individuals...
Company Information
- CEO
- Jan Moller Mikkelsen
- Sector
- Healthcare
- Industry
- Biotechnology
- Employees
- 1017
Contact Information
- Website
- https://ascendispharma.com
- Address
- Tuborg Boulevard 12
- Country
- DK
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Growth-oriented company with premium valuation (P/E: 24.1)
✓ Lower volatility stock (Beta: 0.39) may provide portfolio stability
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Ascendis Pharma A/S shareholders
- ⚠Market volatility can significantly impact stock price, especially for mid-cap stocks
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Ascendis Pharma A/S
- ⚠Investors should consider how Ascendis Pharma A/S fits within their overall portfolio allocation
Market Cap
12.96B
P/E Ratio (TTM)
24.06
Beta
0.39
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare ASND with peer companies:
- Price
- $67.41
- Market cap
- 13.20B
- Price
- $56.17
- Market cap
- 10.86B
- Price
- $52.58
- Market cap
- 13.22B
- Price
- $130.70
- Market cap
- 17.33B
- Price
- $73.32
- Market cap
- 12.12B
- Price
- $471.32
- Market cap
- 10.87B
- Price
- $45.99
- Market cap
- 18.25B
- Price
- $28.41
- Market cap
- 20.43B
- Price
- $144.19
- Market cap
- 30.65B
- Price
- $13.05
- Market cap
- 10.12B
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.